Windlas Biotech Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Komal Gupta

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	8.6yrs
Participación del CEO	n/a
Permanencia media de la dirección	4.1yrs
Promedio de permanencia en la Junta Directiva	4yrs

Actualizaciones recientes de la dirección

Recent updates

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Nov 03

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Aug 20

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 23

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Apr 07

CEO

Komal Gupta

8.6yrs

Permanencia

Ms. Komal Gupta is the Chief Financial Officer of Windlas Biotech Limited since October 16, 2015 and serves as its Chief Executive Office since February 08, 2023. She joined Windlas Biotech on October 16,...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Ashok Windlass	Whole-Time Director	no data	₹15.60m	62.82% ₹ 6.9b
Hitesh Windlass	MD & Executive Director	4.1yrs	₹14.70m	0.000010% ₹ 1.1k
Manoj Windlass	Joint MD & Executive Director	4.1yrs	₹14.70m	0.000030% ₹ 3.3k
Pawan Sharma	Executive Director	no data	₹4.61m	sin datos
Komal Gupta	CFO & CEO	8.6yrs	sin datos	sin datos
Ananta Panda	Company Secretary & Compliance Officer	3.1yrs	sin datos	sin datos
Mohammed Aslam	President of Sales & Marketing	no data	sin datos	sin datos
Om Sule	Site Quality Head	4.4yrs	sin datos	sin datos

4.1yrs

Permanencia media

54.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de WINDLAS se considera experimentado (4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Ashok Windlass	Whole-Time Director	23.3yrs	₹15.60m	62.82% ₹ 6.9b
Hitesh Windlass	MD & Executive Director	16.3yrs	₹14.70m	0.000010% ₹ 1.1k
Manoj Windlass	Joint MD & Executive Director	18.1yrs	₹14.70m	0.000030% ₹ 3.3k
Pawan Sharma	Executive Director	4.9yrs	₹4.61m	sin datos
Gaurav Gulati	Non-Executive Independent Director	3yrs	sin datos	sin datos
Vivek Dhariwal	Non-Executive Independent Chairman	3yrs	sin datos	sin datos
Srinivasan Venkataraman	Non-Executive Independent Director	3yrs	sin datos	sin datos
Prachi Windlass	Non-Executive Director	3yrs	sin datos	0.000010% ₹ 1.1k

4.0yrs

Permanencia media

48yo

Promedio de edad

Junta con experiencia: La junta directiva de WINDLAS se considera experimentada (3.9 años de antigüedad promedio).

Windlas Biotech Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Windlas Biotech Limited, Annual General Meeting, Sep 12, 2023

Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer

Less than half of directors are independent

Windlas Biotech Limited, Annual General Meeting, Sep 19, 2022

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Now 21% overvalued after recent price rise

Now 23% overvalued after recent price rise

Now 21% overvalued after recent price rise

New minor risk - Share price stability

Now 20% overvalued after recent price rise

Third quarter 2024 earnings released: EPS: ₹7.26 (vs ₹4.23 in 3Q 2023)

Windlas Biotech Limited to Report Q3, 2024 Results on Feb 08, 2024

Windlas Biotech Limited to Report Q3, 2024 Results on Feb 08, 2024

Investor sentiment improves as stock rises 22%

Second quarter 2024 earnings released: EPS: ₹6.75 (vs ₹5.59 in 2Q 2023)

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Windlas Biotech Limited to Report First Half, 2024 Results on Nov 08, 2023

Windlas Biotech Limited Approves Final Dividend for the Financial Year 2022-23

Upcoming dividend of ₹4.00 per share at 1.1% yield

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Windlas Biotech Limited, Annual General Meeting, Sep 12, 2023

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: ₹5.79 (vs ₹4.50 in 1Q 2023)

Windlas Biotech Limited to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings released: EPS: ₹19.70 (vs ₹18.58 in FY 2022)

Windlas Biotech Limited Recommends Dividend

Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer

Third quarter 2023 earnings released: EPS: ₹4.23 (vs ₹3.81 in 3Q 2022)

Less than half of directors are independent

Windlas Biotech Limited (BSE:543329) announces an Equity Buyback for INR 250 million worth of its shares.

Second quarter 2023 earnings released: EPS: ₹5.59 (vs ₹4.11 in 2Q 2022)

Windlas Biotech Limited Declares A Final Dividend for the Financial Year 2021-22

Windlas Biotech Limited Proposes Final Dividend for the Financial Year 2021-22

Windlas Biotech Limited, Annual General Meeting, Sep 19, 2022

First quarter 2023 earnings released: EPS: ₹4.50 (vs ₹3.67 in 1Q 2022)

Windlas Biotech Limited to Report Q1, 2023 Results on Aug 04, 2022

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

The Board of Directors of Windlas Biotech Limited, At Their Meeting Held on May 12, 2022, Approves the Dividend of INR 3.5 Per Share

Less than half of directors are independent

Investor sentiment improved over the past week

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

First quarter 2022 earnings released: EPS ₹3.67 (vs ₹0.25 in 1Q 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad